Depression with anxiety and atypical depression
- PMID: 8444829
Depression with anxiety and atypical depression
Abstract
Some forms of anxiety and affective disorder, such as panic disorder and major depression, appear distinct, but frequently symptoms of depression and anxiety occur together. The comorbidity of anxiety and depression not only has implications for the differential diagnosis of the disorder but affects the severity and course of illness and its responsiveness to treatment. The results of studies of atypical depression suggest that this form of depressive illness responds better to monoamine oxidase inhibiting medications than to tricyclic antidepressant agents, and this preferential responsiveness may in fact define the boundaries of atypical depression. The serotonin selective reuptake inhibitor paroxetine seems to have a beneficial effect on symptoms of anxiety and agitation in depressed patients. Further clinical research is needed, however, to determine the best way to manage depression with anxiety and atypical depression.
Similar articles
-
Management of patients with depression associated with anxiety symptoms.J Clin Psychiatry. 1997;58 Suppl 8:11-6. J Clin Psychiatry. 1997. PMID: 9236730 Review.
-
Care of depressed patients with anxiety symptoms.J Clin Psychiatry. 1999;60 Suppl 17:23-7; discussion 46-8. J Clin Psychiatry. 1999. PMID: 10446738 Review.
-
Overview of antidepressants currently used to treat anxiety disorders.J Clin Psychiatry. 1999;60 Suppl 22:18-22. J Clin Psychiatry. 1999. PMID: 10634351 Review.
-
Comorbid depression and anxiety spectrum disorders.Depress Anxiety. 1996-1997;4(4):160-8. doi: 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J. Depress Anxiety. 1996. PMID: 9166648 Review.
-
Anxiety with depression: a treatment need.Eur Neuropsychopharmacol. 1999 Jul;9 Suppl 3:S87-92. doi: 10.1016/s0924-977x(99)00027-9. Eur Neuropsychopharmacol. 1999. PMID: 10523063 Review.
Cited by
-
The role of monoamine oxidase inhibitors in current psychiatric practice.J Psychiatr Pract. 2004 Jul;10(4):239-48. doi: 10.1097/00131746-200407000-00005. J Psychiatr Pract. 2004. PMID: 15552546 Free PMC article.
-
Magnetofection and isolation of DNA using polyethyleneimine functionalized magnetic iron oxide nanoparticles.R Soc Open Sci. 2018 Dec 12;5(12):181369. doi: 10.1098/rsos.181369. eCollection 2018 Dec. R Soc Open Sci. 2018. PMID: 30662742 Free PMC article.
-
A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.Prim Care Companion J Clin Psychiatry. 2008;10(1):25-30. doi: 10.4088/pcc.v10n0105. Prim Care Companion J Clin Psychiatry. 2008. PMID: 18311418 Free PMC article.
-
Current place of monoamine oxidase inhibitors in the treatment of depression.CNS Drugs. 2013 Oct;27(10):789-97. doi: 10.1007/s40263-013-0097-3. CNS Drugs. 2013. PMID: 23934742 Review.
-
Antioxidant effect of phenelzine on MPP+-induced cell viability loss in differentiated PC12 cells.Neurochem Res. 2003 Dec;28(12):1833-41. doi: 10.1023/a:1026119708124. Neurochem Res. 2003. PMID: 14649725
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical